Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Triple Negative Breast Cancer (TNBC) With High TAMs
Interventions: DRUG: MCS110|DRUG: carboplatin|DRUG: gemcitabine
Sponsor: Novartis Pharmaceuticals